A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons
Clinical trial NCT00001060 · COMPLETED
Trial details
- NCT number
- NCT00001060
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.